» Articles » PMID: 32508565

Alzheimer's Disease: What Can We Learn From the Peripheral Olfactory System?

Overview
Journal Front Neurosci
Date 2020 Jun 9
PMID 32508565
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The sense of smell has been shown to deteriorate in patients with some neurodegenerative disorders. In Parkinson's disease (PD) and Alzheimer's disease (AD), decreased ability to smell is associated with early disease stages. Thus, olfactory neurons in the nose and olfactory bulb (OB) may provide a window into brain physiology and pathophysiology to address the pathogenesis of neurodegenerative diseases. Because nasal olfactory receptor neurons regenerate throughout life, the olfactory system offers a broad variety of cellular mechanisms that could be altered in AD, including odorant receptor expression, neurogenesis and neurodegeneration in the olfactory epithelium, axonal targeting to the OB, and synaptogenesis and neurogenesis in the OB. This review focuses on pathophysiological changes in the periphery of the olfactory system during the progression of AD in mice, highlighting how the olfactory epithelium and the OB are particularly sensitive to changes in proteins and enzymes involved in AD pathogenesis. Evidence reviewed here in the context of the emergence of other typical pathological changes in AD suggests that olfactory impairments could be used to understand the molecular mechanisms involved in the early phases of the pathology.

Citing Articles

Olfactory deficits in aging and Alzheimer's-spotlight on inhibitory interneurons.

Elhabbari K, Sireci S, Rothermel M, Brunert D Front Neurosci. 2024; 18:1503069.

PMID: 39737436 PMC: 11683112. DOI: 10.3389/fnins.2024.1503069.


From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.

Sighencea M, Popescu R, Trifu S Int J Mol Sci. 2024; 25(22).

PMID: 39596378 PMC: 11594972. DOI: 10.3390/ijms252212311.


Olfactory bulb stimulation mitigates Alzheimer's-like disease progression.

Salimi M, Nazari M, Shahsavar P, Dehghan S, Javan M, Mirnajafi-Zadeh J CNS Neurosci Ther. 2024; 30(10):e70056.

PMID: 39404073 PMC: 11474698. DOI: 10.1111/cns.70056.


Tactile discrimination as a diagnostic indicator of cognitive decline in patients with mild cognitive impairment: A narrative review.

Xu J, Sun Y, Zhu X, Pan S, Tong Z, Jiang K Heliyon. 2024; 10(10):e31256.

PMID: 38803967 PMC: 11129005. DOI: 10.1016/j.heliyon.2024.e31256.


Role of Ectopic Olfactory Receptors in the Regulation of the Cardiovascular-Kidney-Metabolic Axis.

Beito M, Ashraf S, Odogwu D, Harmancey R Life (Basel). 2024; 14(5).

PMID: 38792570 PMC: 11122380. DOI: 10.3390/life14050548.


References
1.
Reisert J, Zhao H . Perspectives on: information and coding in mammalian sensory physiology: response kinetics of olfactory receptor neurons and the implications in olfactory coding. J Gen Physiol. 2011; 138(3):303-10. PMC: 3171077. DOI: 10.1085/jgp.201110645. View

2.
Wesson D, Borkowski A, Landreth G, Nixon R, Levy E, Wilson D . Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model. J Neurosci. 2011; 31(44):15962-71. PMC: 3417321. DOI: 10.1523/JNEUROSCI.2085-11.2011. View

3.
Rajapaksha T, Eimer W, Bozza T, Vassar R . The Alzheimer's β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol Neurodegener. 2011; 6:88. PMC: 3269394. DOI: 10.1186/1750-1326-6-88. View

4.
Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

5.
Cheng N, Cai H, Belluscio L . In vivo olfactory model of APP-induced neurodegeneration reveals a reversible cell-autonomous function. J Neurosci. 2011; 31(39):13699-704. PMC: 3190161. DOI: 10.1523/JNEUROSCI.1714-11.2011. View